compared to the lyophilized control material."
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Increased concentrations of circulating serotonin (5-hydroxytryptamine)
have been implicated in several pathological conditions that may involve peripheral serotonergic mechanisms: migraine (1), schizophrenia (2), carcinoid syndrome (3), essential hypertension (4), Huntington's disease (5), and Duchenne's muscular dystrophy (6).
Most determinations of serotonin in blood have been performed by relatively insensitive and nonspecific methods such as spectrofluorometry (7) and bio-assay (8). Recently,
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however, the advent of "high-performance" liquid chromatography coupled with electrochemical detection (LC-EC) has provided a highly sensitive and specific means of determining catecholamines, indoleamines, and their respective metabolites (for reviews see references 9, 10).
LC-EC has been used for determinations described for brain extracts (9, 10), cerebrospinal fluid (11, 12), and plasma (13-15), the assays involving various degrees of complexity of sample preparation. However, serotonin from brain is measurable by directly injecting supernates of tissue homogenates into a suitable chromatographic system (10). Here we report the determination of serotonin in simply-treated human plasma. The method is suitable for quantifying plasma serotonin in normal controls and in patients with various disease conditions. We verified the data obtained from the LC-EC analysis by comparison with a classical spectrofluorometric method (7, 16), both for plasma standards and for samples from carcinoid patients. These patients are characterized by a serotonin-secreting tumor, which increases the concentrations of serotonin in blood and urine (3). 
Materials and Methods

Reagents and Standards
5-
Patients
Blood was sampled from three carcinoid-syndrome patients, one man and two women, ages 48 to 63 years. Patient 1 (male) was receiving methysergide hydrogen maleate, 6 mg/day, at the time of sampling. Blood was obtained from one patient (who was drug free) both before and 10 days after surgery for the removal of tumor material. Patient 3 was receiving naproxen, 500 mg daily, at the time of sampling.
Procedures
Chromatography.
The 
Preparation of platelet -poor plasma.
Most circulating serotonin is thought to be contained in blood platelets (17) . To eliminate the possibility of contamination of plasma from this source, we separated platelets from whole blood as follows. Venous blood was collected through a 19-gauge needle into a 38 g/L solution of trisodium citrate (bboodlcitrate, 9/1 by vol). After gentle agitation the mixture was centrifuged (1500 x g, 4 #{176}C, 15 mm). The resulting "plateletpoor plasma" was decanted and stored at -20 #{176}C until required for assay.
Preparation of serotonin plasma standards.
Known amounts of serotonin were added to pooled human plasma obtained from the National Blood Group Reference Laboratory, Oxford, U.K., to prepare a series of standards in plasma, the concentration range being 5 nmol/L to 100 .unoI1L. For comparison, we used 500-L aliquots of platelet-poor plasma and the method of Curzon and Green (7), as modified by
Curzon et al. (16).
Calibration procedure. Anticipating a wide range of plasma concentrations of serotonin between normal and pathological specimens, we considered it impractical to add a suitable compound to function as an internal standard. Consequently, we routinely calibrated with plasma standards before analysis of any sample material.
Specificity of LC-EC determinations.
The retention times and k' values of several biogenic amines and their precursors and metabolites were measured and their potential interference with the assay procedure was estimated. Similar studies were performed on the serotoninergic antagonists methysergide and phenoxybenzamine, drugs sometimes administered to inhibit the gastrointestinal symptoms caused by the serotonin-secreting tumors that characterize the carcinoid syndrome (3). We also investigated the chromatographic characteristics of naproxen and its major metabolite, compounds that reportedly interfere with the assay for urinary indoles commonly used for the diagnosis of carcinoid syndrome (18, 19). Figure 2 illustrates a chromatogram of a standard solution of serotonin, its metabolic precursor 5-hydroxytryptophan, and 5-hydroxyindoleacetic acid, its principal metabolite. Resolution (R8) of serotonin from each of these compounds was complete (R = 2.72 and 1.60, respectively). 
Results
Chromatography
Accuracy
Results by the LC-EC assay for serotonin were compared with data obtained from analysis of the same plasma samples by the spectrofluorometric method of Curzon and Green (7, 16). Correlation between the two procedures was excellent (r = 0.985; Figure 3) . Additionally, the limit of sensitivity of the LC-EC method was superior to the spectrofluorometric method for these small aliquots of plasma (5 nmol/L vs 100 nmoJL). Mean analytical recovery of the LC-EC assay was 93.3% (SEM 3.8%, range 77.3% to 111.2%), as calculated by comparing results for aqueous solutions. This excelled the spectrofluorometric assay (81.9%, SEM 9.1%, range 57.1-140%) over the calibration range. Figure 4 exemplifies the application of the present technique to the determination of serotonin in normal volunteers and patients in whom a carcinoid syndrome had been diagnosed. Results for the patients examined by this method and those by spectrofluorometry correlated well (Table 3) . n CV, % n CV, % n a Below limit of detection. Interassaycv wascalculated fromdeterminations performed on differentdays over the course of one month.
Application
Injection of deproteinated plasma into the liquid chromatograph did not adversely affect chromatographic efficiency. However, the use of a pre-column to protect the analytical column was considered essential. We replaced the pre-column packing every 15 to 20 working days.
Table 3. LC-EC and Fluorometric Determinations of Serotonin in Plasma from Three Patients with
Carcinoid Syndrome Values were not significantly different between the two methods (Students paired t-test). r, calculated by linear regression analysis = 0.964.
Discussion
The development of reliable, commercially available electrochemical detectors has had particular significance in neurochemistry.
The two major groups of monoamine neurotransmitters, the catecholamines and the indoleamines (and their metabolites), as a consequence of their relative ease of oxidation, may be analyzed with high specificity and sensitivity by LC-EC (9, 10).
Most LC-EC techniques for the determination of serotonin have emphasized its role as a neurotransmitter.
With LC-EC one can measure serotonin by injecting the supernate of brain-tissue homogenate directly into the chromatograph. Untreated cerebrospinal fluid has been similarly injected.
Given the current wide interest in the role of serotonin in the normal and pathological function of peripheral organs (4,23), the possibility of accurately and quickly measuring plasma serotonin is of considerable scientific and clinical interest. Our method is accurate, sensitive, and rapid, for both normal and pathological concentrations. Sample preparation involves only deproteination and centrifugation. Furthermore, the technique also allows concurrent measurement of 5-hydroxytryptophan and 5-hydroxyindoleacetic acid, the major precursor and metabolite of serotomn.
Good correlation was observed between values for standard and pathological platelet-poor plasma samples as measured by this method and by spectrofluorometry. The poor recovery by spectrofluorometry at higher serotonin concentrations may account for the discrepancy between the absolute concentrations estimated (Figure 3, slope >1 ).
Recent reports have described analysis for serotonin in plasma by radioenzymatic assay (21), radioimmunoassay (22), and liquid chromatography (with pre-column purification) coupled with either fluorescence detection (24) or electrochemical detection (15). These are all complex, timeconsuming procedures, requiring considerable sample preparation. The present method provides a simple, specific method for monitoring plasma serotonin at the concentrations expected in normal and pathological cases.
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